J. Leonard Lichtenfeld is an oncologist who blogs at Dr. Len’s Blog.
I spent 4 hours on New Year’s Eve sitting in the surgeon’s chair getting a skin cancer taken off my nose. Nothing about the experience fits the “benign” label so many professionals, including yours truly, have used: routine; easy to treat; nothing to worry about. Friends, after this experience, which left me looking like a tall, white-haired Rudolph the …
I attended a meeting recently that got me to thinking about the fact that as we revolutionize cancer research and treatment, we are also going to have to revolutionize cancer care. And that may prove to be an even more daunting task than finding new treatments for the disease itself.
The meeting was sponsored by a collaboration called “Read more…
There was a memorable scene in the movie “The Graduate” from 1967. You may know it or have heard of it, when the older man turns to the college graduate and says the future is all about one word: “plastics.”
Well, plastics may have been then, but this is now. And the core themes I keep hearing these days there are two central …
We’ve all heard the phrase, “When you come to a fork in the road, take it.” Well, that saying may hold particular relevance while reviewing a new research report published in the New England Journal of Medicine.
The report is an important one. It is an 18 year follow-up of a study designed to show whether the use of …
A newspaper story recently caught my eye when it headlined: “Senators Revive Push for End-of-Life-Care Planning.” It reported on new legislation making the rounds in Washington to address care planning for those with advanced illnesses.
You remember “end of life care planning,” don’t you? It was part of the Affordable Care Act debate several years ago, and quickly became translated intoRead more…
As we walk the halls and sit in the lectures at the annual meeting of the American Society of Clinical Oncology, there’s an elephant in the room. It is right there in front of us, but not many of us seem willing to talk about it. Fewer still are making any commitments to do something about it.
So what is …
Another year and another annual meeting for the American Society of Clinical Oncology in Chicago. This is a meeting that regularly attracts many thousands of doctors, researchers, pharmaceutical folks and others interested in the science and business of cancer from around the globe to learn, to discuss, to persuade, to educate on the progress being made in clinical cancer …
Coming to an office near you: a new test that can “confidently” predict whether or not you need to have aggressive therapy for your newly diagnosed prostate cancer.
Really?
That’s what the press reports would lead you to believe. And it’s really going to catch your attention if you’re one of the tens of thousands of men who will have …
I have been diagnosed with skin cancer.
There really isn’t much special about that, since it is a distinction I share with over 2 million Americans who have a skin cancer removed every year. Fortunately, for most, it is a cancer that is not of particular concern since most can be removed. But even those “simple” surgeries–as I have learned …
Groundhog Day was on Saturday this year, and unlike the furry little beast, what I have to say each year around this time is just as good today as him looking for his shadow on Saturday.
What is all this about, you are probably asking yourself?
It is about an annual update that …
We are on a search for truth, but will we ever find it? That summarizes how I feel after reading an article in the New England Journal of Medicine, which once again raises the question of how much screening mammography contributes to the progress we have made in reducing deaths from breast cancer in …
I was recently sitting on an airplane on my way to a far off destination for a meeting preceded by a couple of days of rest and relaxation.
In and of itself, nothing particularly special about that except that maybe a couple of folks will be jealous. But to me, right now it is an incredible moment, the culmination …
David Sampson, who is a colleague of mine here at the American Cancer Society, recently sent me a blog written by a woman well known in the breast cancer community who days previously had been diagnosed with recurrence of her breast cancer. The blog has captivated me, perhaps more so now that I have been facing some of my own …
It has been a long slog since we started our war on cancer here in the United States in 1971.
At times I am not certain that this has been so much of a war as opposed to a series of skirmishes that occasionally have produced incredible moments of optimism. But there have been a fair share of frustrations …
Like many of you, I have been reading the various news stories about Lance Armstrong, especially one recently in a major newspaper, which went into great detail about the allegations surrounding Lance Armstrong’s cycling career.
But what I didn’t see in all of that coverage was much mention of the other side of the man, the side that I …
I have a confession to make.
As soon as I finished reading the Annual Report to the Nation recently, I got up from my desk and took a walk for 20 minutes.
What, might you ask, compelled me to do this?
The answer is what made me take a walk is the same reason I am writing this follow-up commentary. Sitting …
An article released by the Centers for Disease Control and Prevention in their weekly publication Morbidity and Mortality Weekly Report provides an assessment of the progress we have made in the diagnosis and treatment of cancer.
Clearly, since 1971, we have made substantial advances in the cancer treatment. We have become a larger and older nation. …
I am sitting here wringing my hands that so much has been made of some studies reported recently at a major radiology conference which suggest that the impact of the breast cancer screening guidelines released by the United States Preventive Services Task Force (USPSTF) in November 2009 has either been good or bad on doctor and patient …
Get free updates delivered free to your inbox.
